Drugs & Targets PanCAN and the Global Coalition for Adaptive Research form alliance to accelerate pancreatic cancer treatments January 12, 2024Vol.50 No.02
Drugs & Targets New York Proton Center and WiTT Group form strategic partnership to help patients address non-clinical cancer care costs January 12, 2024Vol.50 No.02
Drugs & Targets FDA approves Padcev + Keytruda for locally advanced or metastatic urothelial cancer January 05, 2024Vol.50 No.01
Drugs & Targets European Commission authorizes Jemperli plus chemo in endometrial cancer indication January 05, 2024Vol.50 No.01
Drugs & Targets Infinimmune, Grid Therapeutics form partnership for deep sequencing of B cells for NSCLC drug discovery January 05, 2024Vol.50 No.01
Drugs & Targets FDA approves Iwilfin for adult and pediatric patients with high-risk neuroblastoma December 15, 2023Vol.49 No.46
